Res-Vac Formulation: Each 2 mL (dose) contains: Bordetella bronchiseptica (Bb1 Strain) ... 21.5 x 1010 CFU Bordetella bronchiseptica Toxoid ....... .............. 500 ug Pasteurella multocida, Type A and D..... ....... 21.5 x 1010 CFU Pasteurella multocida Type D Toxoid ............... 500 ug Actinobacillus pleuropneumoniae, Type 2 and 5 ................. ..... 21 x 1010 CFU Actinobacillus pleuropneumoniae, Type 2 and 5 Toxoid .......... ................ 100 ug Glaesserella parasuis, Type 4 and 5 ........... ........ 24 x 10°CFU Mesomycoplasma hyopneumoniae (J101 Strain) .............. ........ 22 x 108 CFU CFU - Colony Forming Unit Suspension for Injection (IM)
Country: Philippines
Language: English
Source: FDA (Food And Drug Administration)
Send request.
Active ingredient:
Inactivated Bordetella bronchiseptica , Pasteurella multocida , Actinobacillus pleuropneumoniae , Glaesserella parasuis , Mesomycoplasma hyopneumoniae Vaccine (Vet.)
Available from:
Nobel Vet, Inc.; Distributor: Nobel Vet, Inc.
INN (International Name):
Inactivated Bordetella bronchiseptica + Pasteurella multocida + Actinobacillus pleuropneumoniae + Glaesserella parasuis + Mesomycoplasma hyopneumoniae Vaccine (Vet.)
Dosage:
Formulation: Each 2 mL (dose) contains: Bordetella bronchiseptica (Bb1 Strain) ... 21.5 x 1010 CFU Bordetella bronchiseptica Toxoid ....... .............. 500 ug Pasteurella multocida, Type A and D..... ....... 21.5 x 1010 CFU Pasteurella multocida Type D Toxoid ............... 500 ug Actinobacillus pleuropneumoniae, Type 2 and 5 ................. ..... 21 x 1010 CFU Actinobacillus pleuropneumoniae, Type 2 and 5 Toxoid .......... ................ 100 ug Glaesserella parasuis, Type 4 and 5 ........... ........ 24 x 10°CFU Mesomycoplasma hyopneumoniae (J101 Strain) .............. ........ 22 x 108 CFU CFU - Colony Forming Unit
Pharmaceutical form:
Suspension for Injection (IM)
Units in package:
PP Bottle with Rubber Stopper, Aluminum Seal and Flip-off Cap x 50 mL (Case of 10's)
Manufactured by:
Komipharm International Co., Ltd., Korea
Authorization date:
2022-08-08
